Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, is offering a new white paper entitled, "Genzyme as Acquisition Target: Opportunities and Risks in its Business and Key Niche Markets." The white paper, which can be viewed at www.DecisionResources.com, answers the following questions:

  --  Why has Genzyme's business attracted the attention of large       pharmaceutical companies?   --  What are the uncertainties that a potential acquirer must consider?   --  What are the prospects for its long dominant position in niche enzyme       replacement therapies?  

Members of the media are welcome to request interviews with the analysts who authored the white paper. Please contact Christopher Comfort at 781-993-2597 to arrange an interview.

About Decision Resources

Decision Resources, Inc. is a world leader in research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. The Company has provided strategic information services for 30 years, assessing international pharmaceutical and health care industry trends. Visit Decision Resources at www.dresources.com.

All company, brand, or product names contained in this document may be trademarks or

  registered trademarks of their respective holders.      For more information, contact:    Christopher Comfort   781-993-2597   ccomfort@dresources.com 

First Call Analyst:
FCMN Contact:

SOURCE: Decision Resources

An Expanding Aging Population and Increases in Diagnosis and Drug Treatment Will Fuel Steady 4.6 Percent Annual Growth in the Chronic Obstructive Pulmonary Drug Market

View Now